Diadema Partners LP 13F 持仓 · 2026年Q2
Diadema Partners 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 78 只证券，申报市值合计 7.91 亿美元。前几大持仓：ABVX（12.86%）、VKTX（9.92%）、BMY（6.78%）。本季前 25 大持仓中：新建仓 7 只、增持 12 只、减持 5 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | $101.8M | 12.86% | 765,244 | 增持 |
| 2 | VKTX | VIKING THERAPEUTICS INC | $78.5M | 9.92% | 2.0M | 增持 |
| 3 | BMY | BRISTOL-MYERS SQUIBB CO | $53.6M | 6.78% | 930,600 | 新建仓 |
| 4 | UTHR | UNITED THERAPEUTICS CORP DEL | $28.7M | 3.63% | 52,989 | 减持 |
| 5 | RVMD | REVOLUTION MEDICINES INC | $26.1M | 3.29% | 139,218 | 减持 |
| 6 | QURE | UNIQURE NV | $24.6M | 3.11% | 534,400 | 减持 |
| 7 | NVS | NOVARTIS AG | $23.5M | 2.97% | 150,000 | 新建仓 |
| 8 | KOD | KODIAK SCIENCES INC | $21.9M | 2.77% | 561,717 | 增持 |
| 9 | CAPR | CAPRICOR THERAPEUTICS INC | $20.8M | 2.63% | 863,700 | 减持 |
| 10 | COGT | COGENT BIOSCIENCES INC | $19.1M | 2.41% | 493,664 | 增持 |
| 11 | BBIO | BRIDGEBIO PHARMA INC | $18.6M | 2.35% | 0 | 持平 |
| 12 | CORT | CORCEPT THERAPEUTICS INC | $17.9M | 2.27% | 206,300 | 增持 |
| 13 | BMRN | BIOMARIN PHARMACEUTICAL INC | $17.9M | 2.26% | 312,846 | 增持 |
| 14 | KYMR | KYMERA THERAPEUTICS INC | $17.2M | 2.17% | 149,700 | 新建仓 |
| 15 | SMMT | SUMMIT THERAPEUTICS INC | $16.3M | 2.06% | 1.1M | 新建仓 |
| 16 | HIMS | HIMS & HERS HEALTH INC | $13.6M | 1.72% | 393,700 | 新建仓 |
| 17 | REPL | REPLIMUNE GROUP INC | $13.3M | 1.68% | 1.2M | 增持 |
| 18 | BIIB | BIOGEN INC | $13.0M | 1.64% | 60,000 | 新建仓 |
| 19 | LLY | ELI LILLY & CO | $12.0M | 1.52% | 10,000 | 增持 |
| 20 | INCY | INCYTE CORP | $11.9M | 1.51% | 105,400 | 减持 |
| 21 | EWTX | EDGEWISE THERAPEUTICS INC | $11.1M | 1.40% | 272,214 | 增持 |
| 22 | RCUS | ARCUS BIOSCIENCES INC | $10.7M | 1.36% | 347,810 | 增持 |
| 23 | BNTX | BIONTECH SE | $9.3M | 1.18% | 100,000 | 新建仓 |
| 24 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $8.8M | 1.11% | 935,064 | 增持 |
| 25 | PCVX | VAXCYTE INC | $8.5M | 1.08% | 147,071 | 增持 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR